RxDoctor Payments Data

Margaret Mary Hayman

Family · Pomeroy, OHNPI 1477532679

Payments from drug & device makers

$1,894in general payments, 2019–2025

Across 112 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$356
  • AstraZeneca$276
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$251
  • Otsuka America Pharmaceutical, Inc.$177
  • Pfizer$114
  • Corcept Therapeutics$103
  • plus $618 from 15 others

What the payments were for

  • Food & beverage$1,87999%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,894 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol53$69,144
EliquisApixaban34$47,544
TrulicityDulaglutide29$45,920
OzempicSemaglutide29$38,284
MounjaroTirzepatide11$30,407
JardianceEmpagliflozin13$22,201
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$19,162
VraylarCariprazine Hcl11$17,460
JanuviaSitagliptin Phosphate13$15,023
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$11,845
LinzessLinaclotide12$10,348
Dexlansoprazole DrDexlansoprazole34$6,617
Albuterol Sulfate HfaAlbuterol Sulfate84$3,413
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,887
Ondansetron OdtOndansetron37$1,315

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$16$76,32740 claims
AstraZenecaFarxiga$276$69,14453 claims
PfizerEliquis$114$47,54434 claims
Novo NordiskOzempic$100$38,28429 claims
Boehringer IngelheimJardiance, Stiolto Respimat$19$34,04628 claims
AbbVieVraylar, Linzess$356$27,80823 claims
GSKTrelegy Ellipta$48$19,16214 claims
MerckJanuvia$33$15,02313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in Pomeroy

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →